unique partnerships
Our Network
Hoosier Cancer Research Network maintains a unique working collaboration between some of the nation’s top academic research centers and community physicians. These partnerships allow HCRN to conduct leading investigator-initiated studies that bring together the best ideas in research and the best care in the clinical setting.

Our Key Opinion Leaders
Sponsor-Investigators
Hoosier Cancer Research Network is honored to collaborate with many thought leaders in clinical oncology research across the United States.
Collaboration and Mentorship
HCRN Clinical Trial Working Groups
Explore below to learn more or to join a group.
Clinical Trial Working Groups
Fostering an Environment of Mentorship
Hoosier Cancer Research Network invites investigators from our member institutions to participate in Clinical Trial Working Groups. Through regular teleconferences and occasional in-person meetings, the group remains active throughout the lifetime of HCRN studies. Fostering an environment of mentorship, these groups are ideal for physicians at all levels in both academic and community settings. CTWGs provide investigators with opportunities to:
Evaluate concepts during the development and design of a protocol
Receive input on concepts from key opinion leaders
Co-author publications
Share best practices in clinical oncology
Meet with funders to discuss areas of interest and concept submission guidelines

Membership Advantages
Member Sites
Membership in the Hoosier Cancer Research Network offers many advantages to both academic research institutions and community health centers. HCRN can assist with trial concept and protocol development, trial management, regulatory and budget assistance, rapid accrual for multi-center trials, electronic data capturing and data support services, site monitoring, publication services and more.
Our highly qualified staff works closely with our members, offering ongoing communication and support, educational webinars, and access to emerging concepts in research through our clinical trial working groups.